EZH2: a novel target for cancer treatment

Enhancer of zeste homolog 2 (EZH2) is enzymatic catalytic subunit of polycomb repressive complex 2 (PRC2) that can alter downstream target genes expression by trimethylation of Lys-27 in histone 3 (H3K27me3). ...

Source: Journal of Hematology and Oncology - July 28, 2020 Category: Hematology Authors: Ran Duan, Wenfang Du and Weijian Guo Tags: Review Source Type: research